tiprankstipranks
Trending News
More News >
bioMerieux (GB:0RUG)
LSE:0RUG
UK Market

bioMerieux (0RUG) Income Statement

Compare
2 Followers

bioMerieux Income Statement

Last quarter (Q2 2025), bioMerieux's total revenue was €2.04B, an increase of 15.46% from the same quarter last year. In Q2, bioMerieux's net income was €161.00M. See bioMerieux’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
€ 3.98B€ 3.67B€ 3.59B€ 3.38B€ 3.12B
Gross Profit
€ 2.22B€ 2.06B€ 1.96B€ 1.97B€ 1.74B
Operating Expenses
€ 1.63B€ 1.62B€ 1.40B€ 1.20B€ 1.19B
Depreciation and Amortization
€ 302.40M€ 259.40M€ 257.60M€ 220.40M€ 228.40M
EBITDA
€ 897.50M€ 701.30M€ 811.90M€ 977.80M€ 747.70M
Operating Income
€ 588.80M€ 439.10M€ 559.80M€ 768.00M€ 551.20M
Other Income/Expenses
€ -9.50M€ -1.60M€ 20.70M€ -9.80M€ -26.80M
Pretax Income
€ 579.30M€ 437.50M€ 550.20M€ 748.30M€ 494.40M
Net Income
€ 432.20M€ 357.60M€ 452.40M€ 601.10M€ 404.40M
Per Share Metrics
Basic EPS
€ 3.67€ 3.03€ 3.84€ 5.08€ 3.42
Diluted EPS
€ 3.64€ 3.01€ 3.82€ 5.06€ 3.41
Weighted Average Shares Outstanding
117.77M 118.05M 117.95M 118.27M 118.15M
Weighted Average Shares Outstanding (Diluted)
118.74M 118.80M 118.44M 118.89M 118.65M
Currency in EUR

bioMerieux Earnings and Revenue History